About
Elios Vision, Inc. is a medical technology company based in Los Angeles, California, dedicated to developing treatments for glaucoma, a major cause of blindness. The company focuses on integrating glaucoma treatment with cataract surgery to enhance patient outcomes. Its flagship product, the ELIOS procedure, utilizes excimer laser technology to create microscopic openings in the eye's trabecular meshwork, facilitating aqueous humor outflow and lowering intraocular pressure. The ELIOS procedure is designed to be performed alongside cataract surgery, targeting patients who have both conditions. This innovative approach aims to set a new standard of care by addressing the needs of approximately 20% of cataract surgery patients who also experience glaucoma or ocular hypertension. Elios Vision has received CE marking in Europe and is currently conducting pivotal trials in the United States. In 2023, the company was acquired by Bausch + Lomb, enhancing their glaucoma treatment offerings.
Technologies
Keywords
Company Information
-
Employees 33
-
Founded 2019
Location
555 S Flower St, Los Angeles, California, United States, 90071-2200